Undisclosed Gene Therapy Portfolio

About LuxFiat Therapeutics

LuxFiat Therapeutics is a private, preclinical-stage biotech developing gene therapies for inherited retinal diseases (IRDs). The company's foundation is built on pioneering research and state-of-the-art animal models from its scientific founders at the University of Pennsylvania, aiming to address significant unmet medical needs in ophthalmology. With a lean operational structure, it is advancing a portfolio of programs toward clinical development, supported by advisors with expertise in biotech entrepreneurship and venture development. The company's strategy capitalizes on the accelerating field of retinal gene therapy to achieve transformational outcomes for patients with inherited blindness.

Therapeutic Areas